Literature DB >> 2696841

Mechanisms of normal and malignant breast epithelial growth regulation.

M E Lippman1, R B Dickson.   

Abstract

In this presentation we review information highlighting the multiple roles of both steroidal and polypeptide regulators of mammary epithelial cell growth with some additional emphasis on the work of our laboratory. The effects of both classes of hormones are complex and involve multiple interactions with epithelial components (malignant or normal) and the stromal compartment. Estrogens induce growth regulatory polypeptide growth factors which are responsible for many of the induced phenotypic effects in hormone-dependent breast cancer. Progression of hormone-dependent breast cancer to hormone independence probably involves multiple genetic mechanisms of oncogene activation, loss of the estrogen receptor, or loss of hormone responsivity of other gene products. Initial carcinogenesis and progression of mammary epithelium to cancer probably also requires both proliferative stimuli (estrogen, polypeptide growth factors) and genetic damage, leading to qualitatively different hormonal responses (hormone responsive cancer). New therapeutic strategies based on these biological considerations are emerging, including a variety of approaches which interfere at multiple points with ability of ligand to induce receptor signaling.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2696841     DOI: 10.1016/0022-4731(89)90071-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  8 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 3.  Molecular biology of breast carcinoma.

Authors:  D el-Ashry; M E Lippman
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

4.  The effects of TGF-alpha and 17 beta-estradiol on polyphosphoinositide metabolism in MCF-7 breast cancer cells.

Authors:  R N Etindi; A Manni; J Martel
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Transforming growth factor-beta 1 inhibits TCDD-induced cytochrome P450IA1 expression in human lung cancer A549 cells.

Authors:  C Vogel; O Döhr; J Abel
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

6.  Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture.

Authors:  I Kim; A Manni; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

7.  Analysis of epidermal growth factor receptor mRNA expression by polymerase chain reaction assay in 94 human breast adenocarcinoma tumors.

Authors:  N S Falette; N Artagaveytia; M C Rostan; E Garin; J Y Bobin; S Saez
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China.

Authors:  Jing Li; Yuan Huang; Bao-Ning Zhang; Jin-Hu Fan; Rong Huang; Pin Zhang; Shu-Lian Wang; Shan Zheng; Bin Zhang; Hong-Jian Yang; Xiao-Ming Xie; Zhong-Hua Tang; Hui Li; Jian-Jun He; Evelyn Hsieh; You-Lin Qiao; Jia-Yuan Li
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.